cabazitaxel accord
accord healthcare s.l.u. - kabatsitakseli - eturauhasen kasvaimet, kastraatio-resistentin - antineoplastiset aineet - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.
orgovyx
accord healthcare s.l.u. - relugolix - prostatiset kasvaimet - endokriinihoito - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
flurbiprofen reckitt benckiser 8.75 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - imeskelytabletti - 8.75 mg - flurbiprofeeni
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiset aineet - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
amitrid 5 mg / 50 mg tabletti
orifarm healthcare a/s - amiloride hydrochloride dihydrate, hydrochlorothiazide - tabletti - 5 mg / 50 mg - hydroklooritiatsidi ja kaliumia säästävät diureetit
spirix 25 mg tabletti
orifarm healthcare a/s - spironolactone - tabletti - 25 mg - spironolaktoni
amitrid mite 2,5 mg / 25 mg tabletti
orifarm healthcare a/s - amiloride hydrochloride dihydrate, hydrochlorothiazide - tabletti - 2,5 mg / 25 mg - hydroklooritiatsidi ja kaliumia säästävät diureetit
spirix 50 mg tabletti
orifarm healthcare a/s - spironolactone - tabletti - 50 mg - spironolaktoni
exemestane accord 25 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - exemestane - tabletti, kalvopäällysteinen - 25 mg - eksemestaani
carbidopa/levodopa fair-med 12.5 mg / 50 mg tabletti
fair-med healthcare gmbh - levodopum,carbidopum monohydricum - tabletti - 12.5 mg / 50 mg - levodopa ja dekarboksylaasin estäjä